ULK4 Activators
ULK4 activators are a class of chemical compounds that specifically target and modulate the activity of the Unc-51 like autophagy activating kinase 4 (ULK4) protein. ULK4 is a serine/threonine kinase that plays a crucial role in the regulation of autophagy, a cellular process that involves the degradation and recycling of damaged or unnecessary cellular components. Autophagy is essential for maintaining cellular homeostasis, and its dysregulation has been implicated in various diseases, including cancer, neurodegenerative disorders, and metabolic conditions. ULK4 activators are designed to enhance the activity of ULK4, thereby promoting autophagy in cells.
The mechanism of action of ULK4 activators involves the direct interaction with ULK4 or its downstream signaling pathways. These activators may function by stabilizing the active conformation of ULK4 or by promoting its phosphorylation, which is essential for its kinase activity. By enhancing ULK4 activity, these compounds facilitate the initiation of autophagy, leading to the formation of autophagosomes and the subsequent degradation of cellular components in the lysosome. ULK4 activators hold great promise in research settings for elucidating the molecular mechanisms of autophagy and its role in various physiological and pathological processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor primarily utilized in cancer therapy to target specific oncogenic kinases, such as BCR-ABL in chronic myeloid leukemia (CML). | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin is an antibiotic that interferes with N-glycosylation, a post-translational protein modification within the endoplasmic reticulum. While Tunicamycin induces endoplasmic reticulum stress, which may activate various cellular pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 functions as a proteasome inhibitor, preventing the degradation of proteins by the proteasome system. This can result in the accumulation of ubiquitinated proteins and activation of stress response pathways. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib is a MEK (mitogen-activated protein kinase kinase) inhibitor that targets the MAPK/ERK signaling pathway. | ||||||